These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 25939302)

  • 21. Hypertriglyceridemia in statin-treated US adults: the National Health and Nutrition Examination Survey.
    Fan W; Philip S; Granowitz C; Toth PP; Wong ND
    J Clin Lipidol; 2019; 13(1):100-108. PubMed ID: 30594443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lipidology update : Evidence-based treatment of dyslipidemia].
    Parhofer KG
    Internist (Berl); 2020 Jun; 61(6):573-586. PubMed ID: 32394074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triglyceride-Rich Lipoproteins and Their Remnants as Silent Promoters of Atherosclerotic Cardiovascular Disease and Other Metabolic Disorders: A Review.
    Sascău R; Clement A; Radu R; Prisacariu C; Stătescu C
    Nutrients; 2021 May; 13(6):. PubMed ID: 34067469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of primary hypertriglyceridemia states--General approach and the role of extracorporeal methods.
    Stefanutti C; Julius U
    Atheroscler Suppl; 2015 May; 18():85-94. PubMed ID: 25936310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacologic approaches for the management of patients with moderately elevated triglycerides (150-499 mg/dL).
    Kelly MS; Beavers C; Bucheit JD; Sisson EM; Dixon DL
    J Clin Lipidol; 2017; 11(4):872-879. PubMed ID: 28669686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent developments in the treatment of hypertriglyceridemia.
    Duriez P; Fruchart JC
    Curr Atheroscler Rep; 1999 Jul; 1(1):31-7. PubMed ID: 11122689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia.
    Christian JB; Arondekar B; Buysman EK; Jacobson TA; Snipes RG; Horwitz RI
    Am J Med; 2014 Jan; 127(1):36-44.e1. PubMed ID: 24384100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospital use and medical care costs up to 5 years after triglyceride lowering among patients with severe hypertriglyceridemia.
    Nichols GA; Arondekar B; Jacobson TA
    J Clin Lipidol; 2012; 6(5):443-9. PubMed ID: 23009780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease?
    Drexel H; Tamargo J; Kaski JC; Lewis BS; Saely CH; Fraunberger P; Dobrev D; Komiyama M; Plattner T; Agewall S; Hasegawa K
    Eur Heart J Cardiovasc Pharmacother; 2023 Sep; 9(6):570-582. PubMed ID: 37328424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of antisense oligonucleotide therapy against apolipoprotein-CIII in hypertriglyceridemia.
    Gouni-Berthold I
    Atheroscler Suppl; 2017 Nov; 30():19-27. PubMed ID: 29096837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triglyceride levels, pancreatitis and choice of lipid-modifying therapy.
    Preiss D
    Expert Rev Gastroenterol Hepatol; 2013 Mar; 7(3):193-5. PubMed ID: 23445227
    [No Abstract]   [Full Text] [Related]  

  • 32. Emerging therapies for atherosclerosis prevention and management.
    Chyu KY; Shah PK
    Cardiol Clin; 2011 Feb; 29(1):123-35. PubMed ID: 21257104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient characteristics and medical care costs associated with hypertriglyceridemia.
    Nichols GA; Arondekar B; Garrison LP
    Am J Cardiol; 2011 Jan; 107(2):225-9. PubMed ID: 21211599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between triglyceride levels and cardiovascular disease in patients with acute pancreatitis.
    Copeland LA; Swendsen CS; Sears DM; MacCarthy AA; McNeal CJ
    PLoS One; 2018; 13(1):e0179998. PubMed ID: 29381696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic targets in the treatment of dyslipidemia: HDL and non-HDL cholesterol].
    Brea Hernando ÁJ
    Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():3-6. PubMed ID: 25043539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bridging the gap in treatment options for patients with hypertriglyceridemia.
    Underberg JA; Hays R
    J Fam Pract; 2007 Dec; 56(12 Suppl New):S24-31. PubMed ID: 18664339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertriglyceridemia in an outpatient department--Significance as an atherosclerotic risk factor.
    Scholz M; Tselmin S; Fischer S; Julius U
    Atheroscler Suppl; 2015 May; 18():146-53. PubMed ID: 25936319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of triglycerides in atherosclerosis.
    Talayero BG; Sacks FM
    Curr Cardiol Rep; 2011 Dec; 13(6):544-52. PubMed ID: 21968696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Approach to the Patient With Moderate Hypertriglyceridemia.
    Subramanian S
    J Clin Endocrinol Metab; 2022 May; 107(6):1686-1697. PubMed ID: 35184196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid disorders in type 2 diabetes.
    Laakso M
    Endocrinol Nutr; 2009 Dec; 56 Suppl 4():43-5. PubMed ID: 20629231
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.